Table 1 Content of the 30-plex antibody panel built for protein profiling in developing human lung tissue

From: High-parametric protein maps reveal the spatial organization in early-developing human lung

 

Antibody-barcode

Targeted protein

In-house conjugation

Targeted main cell type/state

1

CD3-BX015

CD3D, CD3E, CD3G

No

Immune (T-cell, Innate lymphoid cell)

2

CD4-BX021

CD4

No

Immune (T-cell)

3

CD19-BX003

CD19

No

Immune (B-cell)

4

CD31-BX032

CD31/PECAM1

No

Endothelial

5

CD34-BX035

CD34

No

Endothelial

6

CD45-BX001

CD45/PTPRC

No

Immune

7

CD90-BX022

CD90/THY1

No

Mesenchymal (Fibroblast)

8

Podoplanin-BX023

PDPN

No

Lymphatic endothelial, mesothelial

9

HLA-DR-BX026

HLA-DRA, HLA-DRB1,…

No

Immune (Antigen presenting cell)

10

Ki67-BX047

MKI67

No

Proliferation

11

Pan-Cytokeratin-BX019

KRT8, KRT18,…

No

Epithelial

12

E-Cadherin-BX014

CDH1

No

Epithelial

13

EPCAM-BX042

EPCAM

Yes

Epithelial

14

CD123-BX054

CD123/IL3RA

Yes

Immune & Endothelial

15

SOX2-BX024

SOX2

Yes

Epithelial

16

CD144-BX016

CD144/CDH5

Yes

Endothelial

17

ACTA2-BX028

ACTA2

Yes

Mesenchymal (Smooth muscle)

18

CD68-BX010

CD68

Yes

Immune (Macrophage)

19

CD44-BX020

CD44

Yes

Immune

20

DCN-BX013

DCN

Yes

Mesenchymal

21

WT1-BX006

WT1

Yes

Mesenchymal

22

CD163- BX005

CD163

Yes

Immune (Macrophage)

23

COL1A1-BX002

COL1A1

Yes

Mesenchymal

24

CD56-RX029

CD56/NCAM1

Yes

Immune (NK cell)

25

MRC1-BX030

MRC1

Yes

Immune (Macrophage)

26

Vimentin-BX045

VIM

Yes

Mesenchymal

27

PRX-BX052

PRX

Yes

Endothelial

28

CLDN5-BX041

CLDN5

Yes

Endothelial

29

SOX9-BX033

SOX9

Yes

Epithelial

30

TTF1-BX007

TTF1/NKX2-1

Yes

Epithelial

  1. Information sources for targeted cell types: Nikolić et al. 21, for PDPN; Jambusaria et al. 60, for CD123; Ma et al. 61, for SOX9, Yatabe et al. 62, for TTF1. The source for other targets is Sountoulidis et al. 27 and Schupp et al., 202032. Supplementary Table 1 provides information for additional antibodies evaluated to build this antibody panel.